Skip to main content

Foyston, Gordon & Payne Inc

Position in NVS — Novartis AG

CIK 1322853 TORONTO, A6

Position in NVS

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,417,375
-$160,685 QoQ
Shares Held
9,044
-12.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#520
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 10% Shared 0% None 90%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Foyston, Gordon & Payne Inc holds $12,647,439 across 3 Drug Manufacturers - General names. NVS ranks #3 (11.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NVS
Novartis AG
This page
9,044 $1,417,375

All Filings in NVS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,417,375 9,044
2026-03-31 $1,578,060 10,331
2025-12-31 $1,405,722 10,196
2025-09-30 $1,356,779 10,580
2025-06-30 $1,298,679 10,732
2025-03-31 $1,212,010 10,872
2024-12-31 $1,068,853 10,984
2024-09-30 $1,248,082 10,851
2024-06-30 $2,539,709 23,856
2024-03-31 $2,409,544 24,910
2023-12-31 $2,570,292 25,456
2023-09-30 $1,048,139 10,290
2023-06-30 $11,407,068 113,042
2023-03-31 $2,698,360 29,330
2022-12-31 $2,721,872 30,003
2022-09-30 $2,334,875 30,718
2022-06-30 $944,369 11,172
2022-03-31 $2,779,920 31,680
2021-12-31 $2,767,988 31,645
2021-09-30 $3,540,174 43,289
2021-06-30 $3,970,673 43,519
2021-03-31 $4,818,764 56,373
2020-12-31 $5,406,117 57,250
2020-09-30 $5,242,731 60,289
2020-06-30 $5,131,661 58,755
2020-03-31 $5,824,432 70,642